Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Oct 1;102(7):1332–1344. doi: 10.1172/JCI560

Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation.

H Koziel 1, Q Eichbaum 1, B A Kruskal 1, P Pinkston 1, R A Rogers 1, M Y Armstrong 1, F F Richards 1, R M Rose 1, R A Ezekowitz 1
PMCID: PMC508980  PMID: 9769325

Abstract

The macrophage mannose receptor, a pattern recognition molecule and component of innate immunity, mediates binding and phagocytosis of Pneumocystis carinii and likely represents an important clearance mechanism in the lungs of immunocompetent hosts. The purpose of this study was to examine the ability of alveolar macrophages from HIV-infected individuals to bind and phagocytose P. carinii, and to investigate the role of the macrophage mannose receptor in mediating this interaction. Compared with healthy individuals, alveolar macrophage phagocytosis of P. carinii from HIV+ persons was reduced up to 74% (P = 0.02), primarily reflecting a reduction in the number of organisms associated with each macrophage (P = 0.019). Furthermore, macrophages from HIV+ individuals demonstrated up to an 80% (P < 0.05) reduction in mannose receptor surface expression and endocytosis. Mannose receptor affinity was unaltered, and mRNA levels were modestly reduced (P < 0.05). Cells from HIV+ individuals with CD4(+) counts < 200 cells/mm3 (representing individuals at high clinical risk for P. carinii pneumonia) demonstrated the lowest levels of P. carinii phagocytosis and mannose receptor endocytosis. In vitro HIV infection of alveolar macrophages from healthy individuals reduced mannose receptor endocytosis to 53.2% (P < 0.05) and P. carinii binding and phagocytosis to 67.4% (P < 0.05) of control. Our studies suggest that HIV infection may alter innate immunity in the lungs, and that impaired alveolar macrophage mannose receptor-mediated binding and phagocytosis of P. carinii may contribute to the susceptibility of HIV-infected individuals to this opportunistic pulmonary pathogen.

Full Text

The Full Text of this article is available as a PDF (464.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong M. Y., Koziel H., Rose R. M., Arena C., Richards F. F. Indicators of Pneumocystis carinii viability in short-term cell culture. J Protozool. 1991 Nov-Dec;38(6):88S–90S. [PubMed] [Google Scholar]
  2. Armstrong M. Y., Richards F. F. Propagation and purification of rat Pneumocystis carinii in short-term cell culture. J Protozool. 1989 Jan-Feb;36(1):24S–27S. doi: 10.1111/j.1550-7408.1989.tb02677.x. [DOI] [PubMed] [Google Scholar]
  3. Barton E. G., Jr, Campbell W. G., Jr Pneumocystis carinii in lungs of rats treated with cortisone acetate. Ultrastructural observations relating to the life cycle. Am J Pathol. 1969 Feb;54(2):209–236. [PMC free article] [PubMed] [Google Scholar]
  4. Belsito D. V., Sanchez M. R., Baer R. L., Valentine F., Thorbecke G. J. Reduced Langerhans' cell Ia antigen and ATPase activity in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1984 May 17;310(20):1279–1282. doi: 10.1056/NEJM198405173102002. [DOI] [PubMed] [Google Scholar]
  5. Bender B. S., Frank M. M., Lawley T. J., Smith W. J., Brickman C. M., Quinn T. C. Defective reticuloendothelial system Fc-receptor function in patients with acquired immunodeficiency syndrome. J Infect Dis. 1985 Aug;152(2):409–412. doi: 10.1093/infdis/152.2.409. [DOI] [PubMed] [Google Scholar]
  6. Benson R. E., Sanfridson A., Ottinger J. S., Doyle C., Cullen B. R. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J Exp Med. 1993 Jun 1;177(6):1561–1566. doi: 10.1084/jem.177.6.1561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bermudez L. E., Young L. S., Enkel H. Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins. Infect Immun. 1991 May;59(5):1697–1702. doi: 10.1128/iai.59.5.1697-1702.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Berton G., Gordon S. Modulation of macrophage mannosyl-specific receptors by cultivation on immobilized zymosan. Effects on superoxide-anion release and phagocytosis. Immunology. 1983 Aug;49(4):705–715. [PMC free article] [PubMed] [Google Scholar]
  9. Bolaños B., Mitchell T. G. Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum. J Leukoc Biol. 1989 Dec;46(6):521–528. doi: 10.1002/jlb.46.6.521. [DOI] [PubMed] [Google Scholar]
  10. Buhl R., Jaffe H. A., Holroyd K. J., Borok Z., Roum J. H., Mastrangeli A., Wells F. B., Kirby M., Saltini C., Crystal R. G. Activation of alveolar macrophages in asymptomatic HIV-infected individuals. J Immunol. 1993 Feb 1;150(3):1019–1028. [PubMed] [Google Scholar]
  11. Ezekowitz R. A., Austyn J., Stahl P. D., Gordon S. Surface properties of bacillus Calmette-Guérin-activated mouse macrophages. Reduced expression of mannose-specific endocytosis, Fc receptors, and antigen F4/80 accompanies induction of Ia. J Exp Med. 1981 Jul 1;154(1):60–76. doi: 10.1084/jem.154.1.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ezekowitz R. A., Sastry K., Bailly P., Warner A. Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J Exp Med. 1990 Dec 1;172(6):1785–1794. doi: 10.1084/jem.172.6.1785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ezekowitz R. A., Williams D. J., Koziel H., Armstrong M. Y., Warner A., Richards F. F., Rose R. M. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature. 1991 May 9;351(6322):155–158. doi: 10.1038/351155a0. [DOI] [PubMed] [Google Scholar]
  14. Fan J., Bass H. Z., Fahey J. L. Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J Immunol. 1993 Nov 1;151(9):5031–5040. [PubMed] [Google Scholar]
  15. Fearon D. T., Locksley R. M. The instructive role of innate immunity in the acquired immune response. Science. 1996 Apr 5;272(5258):50–53. doi: 10.1126/science.272.5258.50. [DOI] [PubMed] [Google Scholar]
  16. Fels A. O., Cohn Z. A. The alveolar macrophage. J Appl Physiol (1985) 1986 Feb;60(2):353–369. doi: 10.1152/jappl.1986.60.2.353. [DOI] [PubMed] [Google Scholar]
  17. Forte M., Rahelu M., Stubberfield C., Tomkins L., Pithie A., Kumararatne D. In-vitro interaction of human macrophages with Pneumocystis carinii. Int J Exp Pathol. 1991 Oct;72(5):589–598. [PMC free article] [PubMed] [Google Scholar]
  18. Greenspan P., Mayer E. P., Fowler S. D. Nile red: a selective fluorescent stain for intracellular lipid droplets. J Cell Biol. 1985 Mar;100(3):965–973. doi: 10.1083/jcb.100.3.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Harmsen A. G., Chen W. Resolution of Pneumocystis carinii pneumonia in CD4+ lymphocyte-depleted mice given aerosols of heat-treated Escherichia coli. J Exp Med. 1992 Sep 1;176(3):881–886. doi: 10.1084/jem.176.3.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Harmsen A. G., Stankiewicz M. Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med. 1990 Sep 1;172(3):937–945. doi: 10.1084/jem.172.3.937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Harris N., Super M., Rits M., Chang G., Ezekowitz R. A. Characterization of the murine macrophage mannose receptor: demonstration that the downregulation of receptor expression mediated by interferon-gamma occurs at the level of transcription. Blood. 1992 Nov 1;80(9):2363–2373. [PubMed] [Google Scholar]
  22. Hidalgo H. A., Helmke R. J., German V. F., Mangos J. A. Pneumocystis carinii induces an oxidative burst in alveolar macrophages. Infect Immun. 1992 Jan;60(1):1–7. doi: 10.1128/iai.60.1.1-7.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Holmskov U., Malhotra R., Sim R. B., Jensenius J. C. Collectins: collagenous C-type lectins of the innate immune defense system. Immunol Today. 1994 Feb;15(2):67–74. doi: 10.1016/0167-5699(94)90136-8. [DOI] [PubMed] [Google Scholar]
  24. Hoppe C. A., Lee Y. C. The binding and processing of mannose-bovine serum albumin derivatives by rabbit alveolar macrophages. Effect of the sugar density. J Biol Chem. 1983 Dec 10;258(23):14193–14199. [PubMed] [Google Scholar]
  25. Hunninghake G. W., Gadek J. E., Kawanami O., Ferrans V. J., Crystal R. G. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol. 1979 Oct;97(1):149–206. [PMC free article] [PubMed] [Google Scholar]
  26. Kerkau T., Bacik I., Bennink J. R., Yewdell J. W., Húnig T., Schimpl A., Schubert U. The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J Exp Med. 1997 Apr 7;185(7):1295–1305. doi: 10.1084/jem.185.7.1295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Larkin M., Childs R. A., Matthews T. J., Thiel S., Mizuochi T., Lawson A. M., Savill J. S., Haslett C., Diaz R., Feizi T. Oligosaccharide-mediated interactions of the envelope glycoprotein gp120 of HIV-1 that are independent of CD4 recognition. AIDS. 1989 Dec;3(12):793–798. doi: 10.1097/00002030-198912000-00003. [DOI] [PubMed] [Google Scholar]
  28. Limper A. H., Hoyte J. S., Standing J. E. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J Clin Invest. 1997 May 1;99(9):2110–2117. doi: 10.1172/JCI119384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lu W., Israël-Biet D. Virion concentration in bronchoalveolar lavage fluids of HIV infected patients. Lancet. 1993 Jul 31;342(8866):298–298. doi: 10.1016/0140-6736(93)91839-e. [DOI] [PubMed] [Google Scholar]
  30. Maródi L., Schreiber S., Anderson D. C., MacDermott R. P., Korchak H. M., Johnston R. B., Jr Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin Invest. 1993 Jun;91(6):2596–2601. doi: 10.1172/JCI116498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Masur H., Jones T. C. The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J Exp Med. 1978 Jan 1;147(1):157–170. doi: 10.1084/jem.147.1.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Masur H., Ognibene F. P., Yarchoan R., Shelhamer J. H., Baird B. F., Travis W., Suffredini A. F., Deyton L., Kovacs J. A., Falloon J. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med. 1989 Aug 1;111(3):223–231. doi: 10.7326/0003-4819-111-3-223. [DOI] [PubMed] [Google Scholar]
  33. Morganelli P. M., Rogers R. A., Kitzmiller T. J., Bergeron A. Enhanced metabolism of LDL aggregates mediated by specific human monocyte IgG Fc receptors. J Lipid Res. 1995 Apr;36(4):714–724. [PubMed] [Google Scholar]
  34. Murray J. F., Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Part I. Am Rev Respir Dis. 1990 May;141(5 Pt 1):1356–1372. doi: 10.1164/ajrccm/141.5_Pt_1.1356. [DOI] [PubMed] [Google Scholar]
  35. Nakata K., Rom W. N., Honda Y., Condos R., Kanegasaki S., Cao Y., Weiden M. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med. 1997 Mar;155(3):996–1003. doi: 10.1164/ajrccm.155.3.9117038. [DOI] [PubMed] [Google Scholar]
  36. Neese L. W., Standing J. E., Olson E. J., Castro M., Limper A. H. Vitronectin, fibronectin, and gp120 antibody enhance macrophage release of TNF-alpha in response to Pneumocystis carinii. J Immunol. 1994 May 1;152(9):4549–4556. [PubMed] [Google Scholar]
  37. Nicholson J. K., Browning S. W. Ability of 'OptiLyse' lysing/fixing reagents to inactivate HIV-infected H9 cells in whole blood. J Immunol Methods. 1994 Feb 10;168(2):283–284. doi: 10.1016/0022-1759(94)90066-3. [DOI] [PubMed] [Google Scholar]
  38. O'Riordan D. M., Standing J. E., Kwon K. Y., Chang D., Crouch E. C., Limper A. H. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J Clin Invest. 1995 Jun;95(6):2699–2710. doi: 10.1172/JCI117972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. O'Riordan D. M., Standing J. E., Limper A. H. Pneumocystis carinii glycoprotein A binds macrophage mannose receptors. Infect Immun. 1995 Mar;63(3):779–784. doi: 10.1128/iai.63.3.779-784.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. O'Riordan T. G., Baughman R. P., Dohn M. N., Smaldone G. C. Lobar pentamidine levels and Pneumocystis carinii pneumonia following aerosolized pentamidine. Chest. 1994 Jan;105(1):53–56. doi: 10.1378/chest.105.1.53. [DOI] [PubMed] [Google Scholar]
  41. Ofek I., Goldhar J., Keisari Y., Sharon N. Nonopsonic phagocytosis of microorganisms. Annu Rev Microbiol. 1995;49:239–276. doi: 10.1146/annurev.mi.49.100195.001323. [DOI] [PubMed] [Google Scholar]
  42. Phair J., Muñoz A., Detels R., Kaslow R., Rinaldo C., Saah A. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med. 1990 Jan 18;322(3):161–165. doi: 10.1056/NEJM199001183220304. [DOI] [PubMed] [Google Scholar]
  43. Pottratz S. T., Martin W. J., 2nd Mechanism of Pneumocystis carinii attachment to cultured rat alveolar macrophages. J Clin Invest. 1990 Nov;86(5):1678–1683. doi: 10.1172/JCI114891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Pottratz S. T., Paulsrud J., Smith J. S., Martin W. J., 2nd Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein. J Clin Invest. 1991 Aug;88(2):403–407. doi: 10.1172/JCI115318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Radding J. A., Armstrong M. Y., Ullu E., Richards F. F. Identification and isolation of a major cell surface glycoprotein of Pneumocystis carinii. Infect Immun. 1989 Jul;57(7):2149–2157. doi: 10.1128/iai.57.7.2149-2157.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Raveh D., Kruskal B. A., Farland J., Ezekowitz R. A. Th1 and Th2 cytokines cooperate to stimulate mannose-receptor-mediated phagocytosis. J Leukoc Biol. 1998 Jul;64(1):108–113. [PubMed] [Google Scholar]
  47. Roths J. B., Marshall J. D., Allen R. D., Carlson G. A., Sidman C. L. Spontaneous Pneumocystis carinii pneumonia in immunodeficient mutant scid mice. Natural history and pathobiology. Am J Pathol. 1990 May;136(5):1173–1186. [PMC free article] [PubMed] [Google Scholar]
  48. Roy S., Fitz-Gibbon L., Poulin L., Wainberg M. A. Infection of human monocytes/macrophages by HIV-1: effect on secretion of IL-1 activity. Immunology. 1988 Jun;64(2):233–239. [PMC free article] [PubMed] [Google Scholar]
  49. Salahuddin S. Z., Rose R. M., Groopman J. E., Markham P. D., Gallo R. C. Human T lymphotropic virus type III infection of human alveolar macrophages. Blood. 1986 Jul;68(1):281–284. [PubMed] [Google Scholar]
  50. Sastry K., Ezekowitz R. A. Collectins: pattern recognition molecules involved in first line host defense. Curr Opin Immunol. 1993 Feb;5(1):59–66. doi: 10.1016/0952-7915(93)90082-4. [DOI] [PubMed] [Google Scholar]
  51. Schlesinger L. S. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol. 1993 Apr 1;150(7):2920–2930. [PubMed] [Google Scholar]
  52. Shellito J., Suzara V. V., Blumenfeld W., Beck J. M., Steger H. J., Ermak T. H. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest. 1990 May;85(5):1686–1693. doi: 10.1172/JCI114621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Shepherd V. L., Abdolrasulnia R., Garrett M., Cowan H. B. Down-regulation of mannose receptor activity in macrophages after treatment with lipopolysaccharide and phorbol esters. J Immunol. 1990 Sep 1;145(5):1530–1536. [PubMed] [Google Scholar]
  54. Shepherd V. L., Konish M. G., Stahl P. Dexamethasone increases expression of mannose receptors and decreases extracellular lysosomal enzyme accumulation in macrophages. J Biol Chem. 1985 Jan 10;260(1):160–164. [PubMed] [Google Scholar]
  55. Smith P. D., Ohura K., Masur H., Lane H. C., Fauci A. S., Wahl S. M. Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis. J Clin Invest. 1984 Dec;74(6):2121–2128. doi: 10.1172/JCI111637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Stahl P. D. The macrophage mannose receptor: current status. Am J Respir Cell Mol Biol. 1990 Apr;2(4):317–318. doi: 10.1165/ajrcmb/2.4.317. [DOI] [PubMed] [Google Scholar]
  57. Stahl P., Schlesinger P. H., Sigardson E., Rodman J. S., Lee Y. C. Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: characterization and evidence for receptor recycling. Cell. 1980 Jan;19(1):207–215. doi: 10.1016/0092-8674(80)90402-x. [DOI] [PubMed] [Google Scholar]
  58. Taylor M. B., Phillips M., Easmon C. S. Opsonophagocytosis of Pneumocystis carinii. J Med Microbiol. 1992 Apr;36(4):223–228. doi: 10.1099/00222615-36-4-223. [DOI] [PubMed] [Google Scholar]
  59. Taylor M. E., Conary J. T., Lennartz M. R., Stahl P. D., Drickamer K. Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains. J Biol Chem. 1990 Jul 25;265(21):12156–12162. [PubMed] [Google Scholar]
  60. Von Behren L. A., Pesanti E. L. Uptake and degradation of Pneumocystis carinii by macrophages in vitro. Am Rev Respir Dis. 1978 Dec;118(6):1051–1059. doi: 10.1164/arrd.1978.118.6.1051. [DOI] [PubMed] [Google Scholar]
  61. Wallace J. M., Hansen N. I., Lavange L., Glassroth J., Browdy B. L., Rosen M. J., Kvale P. A., Mangura B. T., Reichman L. B., Hopewell P. C. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med. 1997 Jan;155(1):72–80. doi: 10.1164/ajrccm.155.1.9001292. [DOI] [PubMed] [Google Scholar]
  62. Willey R. L., Maldarelli F., Martin M. A., Strebel K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol. 1992 Dec;66(12):7193–7200. doi: 10.1128/jvi.66.12.7193-7200.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Williams D. J., Radding J. A., Dell A., Khoo K. H., Rogers M. E., Richards F. F., Armstrong M. Y. Glucan synthesis in Pneumocystis carinii. J Protozool. 1991 Jul-Aug;38(4):427–437. doi: 10.1111/j.1550-7408.1991.tb01382.x. [DOI] [PubMed] [Google Scholar]
  64. Williams M. D., Wright J. R., March K. L., Martin W. J., 2nd Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages. Am J Respir Cell Mol Biol. 1996 Mar;14(3):232–238. doi: 10.1165/ajrcmb.14.3.8845173. [DOI] [PubMed] [Google Scholar]
  65. Yarchoan R., Klecker R. W., Weinhold K. J., Markham P. D., Lyerly H. K., Durack D. T., Gelmann E., Lehrman S. N., Blum R. M., Barry D. W. Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet. 1986 Mar 15;1(8481):575–580. doi: 10.1016/s0140-6736(86)92808-4. [DOI] [PubMed] [Google Scholar]
  66. Young L. S. Trimethoprim-sulfamethoxazole in the treatment of adults with pneumonia due to Pneumocystis carinii. Rev Infect Dis. 1982 Mar-Apr;4(2):608–613. doi: 10.1093/clinids/4.2.608. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES